SCHEMBL4284998

SCHEMBL4284998

COC1O[C@H](CO)[C@H](O)[C@H](OC2O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]2O)[C@@H]1O

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LGALS8 O00214 3/20 0.56
▸ MEN1 O00255 2/20 0.52
▸ KMT2A Q03164 2/20 0.52
▸ CD209 Q9NNX6 1/20 0.48
▸ LGALS3 P17931 2/20 0.48
▸ LGALS4 P56470 1/20 0.48
▸ GJA1 P17302 1/20 0.47
▸ GJB2 P29033 1/20 0.47
▸ CYP2C9 P11712 1/20 0.47
▸ TSHR P16473 1/20 0.47
▸ ALDH1A1 P00352 1/20 0.47
▸ LGALS9 O00182 1/20 0.46
▸ LGALS1 P09382 1/20 0.46
▸ LGALS7; LGALS7B P47929 1/20 0.46
▸ L3MBTL1 Q9Y468 1/20 0.46
▸ ENGASE Q8NFI3 1/20 0.46
▸ FGF1 P05230 1/20 0.46
▸ FGF2 P09038 1/20 0.46
▸ VEGFA P15692 1/20 0.46
▸ HPSE Q9Y251 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5526345 1.00 LGALS8 (0.56) LGALS8MEN1KMT2ACD209LGALS3
SCHEMBL5514966 1.00 LGALS8 (0.56) LGALS8MEN1KMT2ACD209LGALS3
SCHEMBL20034302 1.00 LGALS8 (0.56) LGALS8MEN1KMT2ACD209LGALS3
SCHEMBL16316509 1.00 LGALS8 (0.56) LGALS8MEN1KMT2ACD209LGALS3
SCHEMBL4260234 1.00 LGALS8 (0.56) LGALS8MEN1KMT2ACD209LGALS3
SCHEMBL15730308 1.00 LGALS8 (0.56) LGALS8MEN1KMT2ACD209LGALS3
SCHEMBL6415085 1.00 LGALS8 (0.56) LGALS8MEN1KMT2ACD209LGALS3
SCHEMBL6820046 1.00 LGALS8 (0.56) LGALS8MEN1KMT2ACD209LGALS3
SCHEMBL4285005 1.00 LGALS8 (0.56) LGALS8MEN1KMT2ACD209LGALS3
SCHEMBL4280409 1.00 LGALS8 (0.56) LGALS8MEN1KMT2ACD209LGALS3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3398606-B1 MICROALGAE-DERIVED COMPOSITIONS FOR IMPROVING THE HEALTH AND APPEARANCE OF SKIN ALGENIST HOLDINGS INC (US) 2021-09-15 — — EP disclosed
US-20180353393-A1 MICROALGAE-DERIVED COMPOSITIONS FOR IMPROVING THE HEALTH AND APPEARANCE OF SKIN ALGENIST HOLDINGS, INC. (US) 2018-12-13 — — US disclosed
EP-3398606-A1 MICROALGAE-DERIVED COMPOSITIONS FOR IMPROVING THE HEALTH AND APPEARANCE OF SKIN TerraVia Holdings, Inc. (US) 2018-11-07 — — EP disclosed
US-9993399-B2 Microalgae-derived compositions for improving the health and appearance of skin ALGENIST HOLDINGS, INC. (US) 2018-06-12 — — US disclosed
EP-1986665-B1 MICROALGAE-DERIVED COMPOSITIONS FOR IMPROVING THE HEALTH AND APPEARANCE OF SKIN TERRAVIA HOLDINGS INC (US) 2018-05-02 — — EP disclosed
US-20150140051-A1 Microalgae-Derived Compositions for Improving the Health and Appearance of Skin ALGENIST BRANDS LLC 2015-05-21 — — US disclosed
US-8956852-B2 Heterotrophic cultivation of hydrocarbon-producing microalgae SOLAZYME, INC. (US) 2015-02-17 — — US disclosed
US-8932652-B2 Microalgae-derived compositions for improving the health and appearance of skin SOLAZYME, INC. (US) 2015-01-13 — — US disclosed
US-20130071909-A1 Heterotrophic Cultivation of Hydrocarbon-Producing Microalgae SOLAZYME, INC. (US) 2013-03-21 — — US disclosed
US-20130004554-A1 Microalgae-Derived Compositions for Improving the Health and Appearance of Skin SOLAZYME, INC. (US) 2013-01-03 — — US disclosed
US-20090285850-A1 Oral Carotenoid Supplementation Methods for Improving the Health and Appearance of Skin SOLAZYME, INC. (US) 2009-11-19 — — US disclosed
US-20090274736-A1 Nutraceutical Compositions From Microalgae And Related Methods of Production And Administration SOLAZYME INC. (US) 2009-11-05 — — US disclosed
US-20080299147-A1 Microalgae-Derived Compositions For Improving The Health And Appearance Of Skin SOLAZYME, INC. (US) 2008-12-04 — — US disclosed
US-20070191303-A1 Polysaccharide compositions and methods of producing, screening, and formulating polysaccharide compositions SOLAZYME, INC. (US) 2007-08-16 — — US disclosed
US-20070167396-A1 Methods and compositions for cholesterol reduction in mammals SOLAZYME, INC. (US) 2007-07-19 — — US disclosed
US-20070166449-A1 Methods and compositions for thickening, stabilizing and emulsifying foods SOLAZYME, INC. (US) 2007-07-19 — — US disclosed
US-20070167398-A1 Methods and compositions for reducing inflammation and preventing oxidative damage SOLAZYME, INC. (US) 2007-07-19 — — US disclosed
US-20070167397-A1 Methods and compositions for joint lubrication SOLAZYME, INC. (US) 2007-07-19 — — US disclosed
US-20070166797-A1 Devices and solutions for prevention of sexually transmitted diseases SOLAZYME, INC. (US) 2007-07-19 — — US disclosed
US-20070166266-A1 Methods and compositions for improving the health and appearance of skin SOLAZYME, INC. (US) 2007-07-19 — — US disclosed
Send feedback